Close
Back to ETON Stock Lookup
Pages: 1 2 3 4 5 »» Last Page

(ETON) – Company Press Releases

Mar 22, 2024 02:20 AM Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Mar 22, 2024 02:00 AM Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
Mar 22, 2024 02:00 AM Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
Mar 14, 2024 04:01 PM Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 29, 2024 04:01 PM Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
Feb 21, 2024 06:50 AM Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
Feb 2, 2024 06:50 AM Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
Nov 9, 2023 04:01 PM Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
Oct 30, 2023 06:50 AM Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
Oct 18, 2023 08:00 AM SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Oct 4, 2023 06:50 AM Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
Aug 23, 2023 06:50 AM Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 10, 2023 04:01 PM Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
Aug 1, 2023 04:05 PM Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
Jul 17, 2023 04:05 PM SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Jun 28, 2023 06:50 AM Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
May 11, 2023 04:01 PM Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
May 10, 2023 06:50 AM Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)
May 3, 2023 04:05 PM Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
Mar 16, 2023 04:01 PM Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
Mar 16, 2023 04:01 PM Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
Mar 15, 2023 06:50 AM Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
Mar 15, 2023 06:50 AM Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
Mar 7, 2023 04:05 PM Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
Mar 7, 2023 04:05 PM Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
Jan 31, 2023 08:00 AM SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Jan 11, 2023 06:50 AM Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
Jan 11, 2023 06:50 AM Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
Nov 10, 2022 04:05 PM Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 10, 2022 04:05 PM Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 2, 2022 04:05 PM Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
Nov 2, 2022 04:05 PM Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
Oct 18, 2022 04:05 PM SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Oct 18, 2022 06:50 AM Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
Oct 18, 2022 06:50 AM Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
Sep 13, 2022 09:00 AM Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
Sep 13, 2022 09:00 AM Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
Aug 30, 2022 04:05 PM Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 30, 2022 04:05 PM Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 11, 2022 04:01 PM Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
Aug 11, 2022 04:01 PM Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
Aug 2, 2022 08:00 AM Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Aug 2, 2022 08:00 AM Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Jul 18, 2022 07:05 AM Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
Jul 18, 2022 07:05 AM Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
Jun 24, 2022 09:09 AM Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
Jun 24, 2022 07:30 AM Eton Pharmaceuticals Announces Sale of Hospital Products
Jun 24, 2022 07:30 AM Eton Pharmaceuticals Announces Sale of Hospital Products
May 12, 2022 04:02 PM Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
May 12, 2022 04:02 PM Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
Pages: 1 2 3 4 5 »» Last Page

Back to ETON Stock Lookup